March 4, 2019
BTG shareholders approve $4.2B Boston Scientific buyout
Photo | Courtesy
Boston Scientific is headquartered in Marlborough.
By Zachary Comeau
The shareholders of British medical device maker BTG have overwhelmingly approved Boston Scientific’s buyout offer of more than $4 billion.
In a U.S. Securities & Exchange Commission filing last week, Boston Scientific confirmed the company’s approval.
More than 95 percent of BTG’s shareholders affected by the transaction approved the deal.
The deal is expected to close around the middle of the year.
Last week, Boston Scientific said it closed a $4.3-billion debt offering it plans to use to help fund the acquisition.
The $4.24-billion offer is more than 36 percent over BTG’s closing price on Nov. 20, the day prior to the announcement of the acquisition.
WBJ Web Partners
Most Recent
Most Recent
0 Comments